{"id":"c-primary-immunizations-with-ixiaro","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Injection site pain or erythema"},{"rate":"5-15","effect":"Myalgia"},{"rate":"5-15","effect":"Headache"},{"rate":"1-5","effect":"Fever"},{"rate":"5-10","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ixiaro contains inactivated Japanese encephalitis virus derived from the SA 14-14-2 strain, which primes both humoral and cell-mediated immune responses. Upon vaccination, the immune system recognizes viral antigens and generates neutralizing antibodies and T-cell responses that protect against infection with wild-type Japanese encephalitis virus. This provides protection against Japanese encephalitis, a potentially fatal neuroinflammatory disease transmitted by Culex mosquitoes in Asia and the Western Pacific.","oneSentence":"Ixiaro is an inactivated Japanese encephalitis virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:04:42.649Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary immunization against Japanese encephalitis in endemic regions and travelers to endemic areas"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ixiaro"],"phase":"phase_3","status":"active","brandName":"C) primary immunizations with Ixiaro","genericName":"C) primary immunizations with Ixiaro","companyName":"Helsinki University Central Hospital","companyId":"helsinki-university-central-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"Ixiaro is an inactivated Japanese encephalitis virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. Used for Primary immunization against Japanese encephalitis in endemic regions and travelers to endemic areas.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}